Visualizing cancer and response to therapy in vivo using Cy5.5-labeled factor VIIa and anti-tissue factor antibody

We have developed a specific technique for imaging cancer in vivo using Cy5.5-labeled factor VIIa (fVIIa), clotting-deficient FFRck-fVIIa, paclitaxel-FFRck-fVIIa, and anti-tissue factor (TF) antibody. FVIIa is the natural ligand for TF. We took advantage of the fact that vascular endothelial cells (...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Drug Target
Main Authors: Zhu, Shijun, Kisiel, Walter, Lu, Yang J., Petersen, Lars C., Ndungu, John M., Moore, Terry W., Parker, Ernest T., Sun, Aiming, Sarkaria, Jann N., Snyder, James P., Liotta, Dennis C., Brat, Daniel J., El-Rayes, Bassel F., Shoji, Mamoru
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4625384/
https://ncbi.nlm.nih.gov/pubmed/25510254
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/1061186X.2014.988217
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados